Navidea Biopharmaceuticals Inc $1.40

up +0.03


14/7/2014 11:04 AM  |  AMEX : NAVB  
Industries : Health Services / Medical Appliances & Equipment
Get Trend Analysis Icon Get NAVB Trend Analysis - it has underperformed the S&P 500 by 70%

Partner Headlines

  1. UPDATE: Navidea Biopharma Announces Positive Lymphoseek Injection Results

    Benzinga
  2. Navidea Announces Presentation of Study Findings of Manocept Platform Imaging ...

    Benzinga
  3. UPDATE: Navidea Biopharma Offers Update on EMA Application For Lymphoseek, ...

    Benzinga
  4. Morning Gainers for Mar. 6, 2014: PXLW, SGMO, ERII, RGSE, NAVB, PSTI

    Benzinga
  5. Morning Movers for Mar. 5, 2014: FCEL, ARWR, SWHC, CPST Moving Higher

    Benzinga
  6. Navidea Announces EMA Continues Marketing Authorization Application Review ...

    Benzinga
  7. Stocks Hitting 52-Week Lows

    Benzinga
  8. US Stock Futures Up Ahead Of Jobless Claims

    Benzinga
  9. Navidea Biopharmaceuticals Announces Agreement with FDA on Special Protocol ...

    Benzinga
  10. Navidea to Collaborate with Maimonides Medical Center on Trial Utilizing ...

    Benzinga
  11. UPDATE: Aegis Capital Initiates Navidea Biopharmaceuticals at Hold

    Benzinga
  12. Navidea Biopharma Offers Interim Analysis Point of Phase 3 Head, Neck Cancer ...

    Benzinga
  13. Navidea Submits Lymphoseek Marketing Application in Europe

    Benzinga
  14. Navidea to Present Data from Lymphoseek Studies at RSNA, CTRC-AACR Meetings

    Benzinga
  15. Navidea Biopharma Says PDUFA Goal Date for Lymphoseek April 30, 2013

    Benzinga
  16. Navidea Biopharmaceuticals Announces the Presentation of Lymphoseek Data ...

    Benzinga
  17. Morning Market Losers

    Benzinga
  18. Benzinga's Top Pre-Market Losers

    Benzinga
  19. Navidea Biopharmaceuticals Announces $50M Credit Facility with Platinum-Montaur ...

    Benzinga
  20. Biotechs With Upcoming PDUFA Dates

    Benzinga
  21. MModal, Unilever Among Stocks Up on High Volume Tuesday

    FoxBusiness
  22. Meta-analysis of Navidea Biopharmaceuticals Lymphoseek® Phase 3 Data Compared ...

    Benzinga
Trading Center